Trinity Biotech | TRIB - Equity Capital And Reserves


Trinity Biotech reported $-71.98M in Equity Capital and Reserves for its fiscal quarter ending in December of 2025.





Equity Capital And Reserves Change Date
Abbott USD 52.06B 69M Mar/2026
Bayer EUR 28.85B 2.9B Mar/2026
Bio-Rad Laboratories USD 6.85B 602.3M Mar/2026
EDAP TMS EUR 23.32M 4.5M Sep/2025
J&J USD 81.19B 358M Mar/2026
Mesa Laboratories USD 186.69M 8.22M Dec/2025
OraSure Technologies USD 313.32M 27.5M Mar/2026
Plus Therapeutics USD 11.96M 7.96M Mar/2026
Roche Holding CHF 33.8B 758M Dec/2025
Siemens EUR 64.39B 1.09B Mar/2026
Thermo Fisher Scientific USD 51.93B 1.6B Mar/2026
Tosoh JPY 831.79B 28.49B Mar/2026
Trinity Biotech USD -71.98M 17.26M Dec/2025
Veracyte USD 1.34B 34.83M Mar/2026